Real-life adherence to subcutaneous immunotherapy: What has changed in the era of the COVID-19 pandemic

Background: Allergen immunotherapy (AIT) must be continued for 3 years, to achieve a long-term modifying effect. Adherence is a key to ensure effectiveness. The objective of this study was, first of all, to evaluate the adherence with subcutaneous immunotherapy (SCIT) and to identify the main causes...

Full description

Bibliographic Details
Main Authors: Ilkay Koca Kalkan, Hale Ates, Kurtulus Aksu, Selma Yesilkaya, Musa Topel, Dilek Cuhadar Ercelebi, Suleyman Turkyilmaz, Ali Oncul, Senay Demir
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:World Allergy Organization Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455121000521